bluebird bio Inc. (NASDAQ: BLUE) stock closed at 3.86 per share at the end of the most recent trading day (a 0.52% change compared to the prior day closing price) with a volume of 3.36M shares and market capitalization of 422.04M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1213 people. bluebird bio Inc. CEO is Nick Leschly.

The one-year performance of bluebird bio Inc. stock is -49.8%, while year-to-date (YTD) performance is -44.22%. BLUE stock has a five-year performance of -96.86%. Its 52-week range is between 2.52 and 8.58, which gives BLUE stock a 52-week price range ratio of 22.11%

bluebird bio Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 4.10, a price-to-sale (PS) ratio of 176.89, a price to cashflow ratio of 5.70, a PEG ratio of -0.02, a ROA of -54.85%, a ROC of -61.02% and a ROE of -101.27%. The company’s profit margin is -%, its EBITDA margin is -8 486.30%, and its revenue ttm is $3.53 Million , which makes it $0.04 revenue per share.

Of the last four earnings reports from bluebird bio Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.69 for the next earnings report. bluebird bio Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for bluebird bio Inc. is Moderate Buy (2.52), with a target price of $6.88, which is +78.24% compared to the current price. The earnings rating for bluebird bio Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

bluebird bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

bluebird bio Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.27, ATR14 : 0.29, CCI20 : 119.54, Chaikin Money Flow : 0.05, MACD : 0.22, Money Flow Index : 42.80, ROC : 27.18, RSI : 62.13, STOCH (14,3) : 79.23, STOCH RSI : 0.64, UO : 52.38, Williams %R : -20.77), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of bluebird bio Inc. in the last 12-months were: Andrew Obenshain (Sold 3 178 shares of value $24 802 ), Colvin Richard A. (Sold 557 shares of value $4 345 ), Klima Thomas (Sold 4 130 shares of value $14 455 ), Leschly Nick (Sold 4 290 shares of value $33 462 ), Nick Leschly (Sold 4 290 shares of value $33 480 ), Obenshain Andrew (Sold 3 178 shares of value $24 788 ), Richard A. Colvin (Sold 557 shares of value $4 347 )